LENZ Therapeutics (LENZ) Earnings Date & Reports

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LENZ is expected to report earnings to fall 25.76% to -98 cents per share on August 19

LENZ Therapeutics LENZ Stock Earnings Reports

Q2'26

Est.

$-0.98

Q1'26

Missed

by $0.15

Q4'25

Missed

by $0.40

Q3'25

Missed

by $0.19

Q2'25

Beat

by $0.08

The last earnings report on May 11 showed earnings per share of -132 cents, missing the estimate of -116 cents. With 146.51K shares outstanding, the current market capitalization sits at 212.90M.

View a ticker or compare two or three

Compare

LENZ

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for LENZ